Compare Boston Scientific Corporation (BSX) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Boston Scientific Corporation trades at $43.36 (market cap $66.37B), while iShares 1 3 Year Treasury Bond ETF trades at $81.96. The key difference: iShares 1 3 Year Treasury Bond ETF is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | SHY | |
|---|---|---|
Market Cap | $66.37B | — |
Sector | Health | Fixed Income |
52-Week High | $108.14 | $83.18 |
52-Week Low | $42.63 | $81.79 |
Enterprise Value | $75.94B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SHY, a US Treasury bond ETF, trades at $81.79, down 0.11% with a bearish technical signal from moving averages. The fund maintains consistent dividend distributions of $0.24 per share scheduled through mid-2026. Current market sentiment reflects significant investor interest in cash and Treasury ETFs as bond yields rise, with nearly $100 billion flowing into cash ETFs according to recent reports.
The outlook for SHY remains tied to Federal Reserve policy decisions amid inflation concerns. While the ETF provides stable income through Treasury exposure, rising rate expectations could pressure short-term bond prices. Investors seeking yield may find competition from higher-yielding alternatives as Treasury yields approach 4% levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
